President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S….
Check out the companies making headlines in midday trading: T-Mobile — Shares pulled back 11% after the company’s wireless subscribers for the first quarter missed Wall Street estimates. T-Mobile reported 495,000 postpaid phone additions in the first-quarter, while analysts polled by StreetAccount were looking for 504,000. Alphabet — The Google parent company gained about 2%…
Check out the companies making headlines in after-hours trading. Alphabet – Shares of the Google-parent gained about 5% after its first-quarter results topped Wall Street’s expectations. Alphabet earned $2.81 per share on $90.23 billion in revenue for the quarter, while analysts surveyed by LSEG had expected $2.01 per share and $89.12 billion in revenue. Intel…
Check out the companies making headlines in midday trading: Autodesk — Shares of the design software maker rose nearly 4% after Starboard Value said it is preparing to wage a proxy fight and intends to nominate a minority slate of director candidates ahead of the company’s upcoming annual meeting. MicroStrategy — The company, which is now going…
Check out the companies making headlines before the bell. HealthEquity — Shares of the health-focused fintech company plunged 15% following weaker-than-expected fourth quarter earnings. HealthEquity, posted non-GAAP earnings per share of 69 cents on revenue of $311.8 million. Analysts polled by FactSet expected earnings of 72 cents per share on revenue of $305.8 million. General…
A little-known biotech company stunned the biopharmaceutical industry last spring when it declared an “unprecedented” achievement: its experimental cancer drug looked more effective than Merck‘s Keytruda in a clinical trial. The company, Summit Therapeutics, licensed the drug from Chinese company Akeso Inc. In October, a group of life science investors announced they were putting $400…
Check out the companies making headlines in extended trading: DoorDash — The food delivery stock traded nearly 6% higher after better-than-expected revenue for the fourth quarter. DoorDash reported revenue of $2.87 billion in its most recent quarter, while analysts surveyed by LSEG forecast $2.84 billion. Gilead Sciences — The biopharmaceutical stock advanced 4% after fourth-quarter…
